Update on biologic safety for patients with psoriasis during pregnancy

DSpace/Manakin Repository

Update on biologic safety for patients with psoriasis during pregnancy

Citable link to this page

 

 
Title: Update on biologic safety for patients with psoriasis during pregnancy
Author: Porter, Martina L.; Lockwood, Stephen J.; Kimball, Alexa B.

Note: Order does not necessarily reflect citation order of authors.

Citation: Porter, Martina L., Stephen J. Lockwood, and Alexa B. Kimball. 2016. “Update on biologic safety for patients with psoriasis during pregnancy.” International Journal of Women's Dermatology 3 (1): 21-25. doi:10.1016/j.ijwd.2016.12.003. http://dx.doi.org/10.1016/j.ijwd.2016.12.003.
Full Text & Related Files:
Abstract: Biologic agents have become more common to treat patients with psoriasis, but concerns about their effect on pregnancy and lactation often preclude this treatment during these time periods. During the past decade, we have gained a much better understanding of the course of psoriasis during pregnancy and the safety of the use of biologic agents during pregnancy and lactation. Under certain circumstances, biologic agents can be considered appropriate treatment options for patients who are pregnant or lactating.
Published Version: doi:10.1016/j.ijwd.2016.12.003
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419021/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:33029907
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters